MTI MEDICAL products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore pharmaceutical manufacturer with specialist injectable and lyophilization capabilities alongside a broad branded-product portfolio.
MTI MEDICAL products in Pakistan
MTI MEDICAL (PVT.) LTD has 59 medicine presentations registered in Pakistan under 31 brands, covering 32 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Pain & musculoskeletal. Its brands with the most registered strengths and packs are Cytozon (Ceftriaxone), Cyto (Ciprofloxacin), Gotec (Omeprazole, Omeprazole enteric coated pellets) and Mizec (Cefotaxime). 59 products have an official DRAP price on MedInfoBase. See all 31 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- MTI Medical (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 586-588, Sundar Industrial Estate, Lahore, Pakistan
- Website
- mtipk.com ↗
- Phone
- +92 42 35297494-8
- info@mtipk.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where MTI MEDICAL (PVT.) LTD is priced against the market
44 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amphotericin B | Amphotericin B | 50 mg | Lyophilized powder for injection | 1's | 119308 | PKR 1,349.10 | PKR 1,349.10/vial/unit | 🔒 Pharma Pro |
| Antamin | Ketamine | 500 mg | Injection | 10ml* 1's vial | 081866 | PKR 199.73 | — | No comparator |
| Apholac | Lactulose | 3.35 g/5 mL | Oral solution | 240ml | 097595 | PKR 508.41 | PKR 2.12/mL | No comparator |
| Apholac | Lactulose | 3.35 g/5 mL | Oral solution | 120ml | 097595 | PKR 268.73 | PKR 2.24/mL | No comparator |
| Arpes | Aciclovir | 250 mg | Injection | Lyophilized 1's vial | 084916 | PKR 708.14 | — | No comparator |
| Bactidim | Ceftazidime | 250 mg | Injection | 1's vial | 084905 | PKR 156.97 | PKR 156.97/vial/unit | 🔒 Pharma Pro |
| Bactidim | Ceftazidime | 1 g | Injection | 1's vial | 084907 | PKR 448.50 | PKR 448.50/vial/unit | 🔒 Pharma Pro |
| Celsius | Paracetamol | 120 mg | Suspension | 100ml | 081853 | PKR 110.02 | PKR 1.10/mL | 🔒 Pharma Pro |
| Celsius | Paracetamol | 120 mg/5 mL | Suspension | 60ml | 081853 | PKR 66.01 | PKR 1.10/mL | 🔒 Pharma Pro |
| Clomate | Clomifene citrate | 50 mg | Tablet | 10's | 091802 | PKR 392.21 | PKR 39.22/tablet | 🔒 Pharma Pro |
| Colimate | Colistimethate sodium | 1 MIU | Injection | 1's | 097779 | PKR 1,199.81 | PKR 1,199.81/vial/unit | 🔒 Pharma Pro |
| Cyto | Ciprofloxacin | 250 mg | Tablet | 10's | 078863 | PKR 236.05 | PKR 23.61/tablet | 🔒 Pharma Pro |
| Cyto | Ciprofloxacin | 500 mg | Tablet | 10's | 078864 | PKR 390.39 | PKR 39.04/tablet | 🔒 Pharma Pro |
| Cyto | Ciprofloxacin | 250 mg/5 mL | Suspension | 60ml | 105972 | PKR 276.31 | PKR 4.61/mL | 🔒 Pharma Pro |
| Cytozon | Ceftriaxone | 2 g | IV injection | 1's vial | 084896 | PKR 817.09 | PKR 817.09/vial/unit | 🔒 Pharma Pro |
| Cytozon | Ceftriaxone | 1 g | IV injection | 1's vial | 084897 | PKR 582.86 | PKR 582.86/vial/unit | 🔒 Pharma Pro |
| Cytozon | Ceftriaxone | 500 mg | IV injection | 1's vial | 084898 | PKR 308.68 | PKR 308.68/vial/unit | 🔒 Pharma Pro |
| Cytozon | Ceftriaxone | 250 mg | IV injection | 1's vial | 084899 | PKR 183.39 | PKR 183.39/vial/unit | 🔒 Pharma Pro |
| Cytozon | Ceftriaxone | 500 mg | IM injection | 1's vial | 084900 | PKR 308.68 | PKR 308.68/vial/unit | 🔒 Pharma Pro |
| Cytozon | Ceftriaxone | 250 mg | IM injection | 1's vial | 084901 | PKR 183.39 | PKR 183.39/vial/unit | 🔒 Pharma Pro |
| Dopacin HCl | Dopamine HCl | 200 mg/5 mL | Injection | 5's*1ml vial | 081861 | PKR 127.10 | — | No comparator |
| Dragrel | Clopidogrel | 75 mg | Tablet | 10's | 112038 | PKR 324.68 | PKR 32.47/tablet | 🔒 Pharma Pro |
| Gotec | Omeprazole enteric coated pellets | 40 mg | Capsule | 2*7's | 078858 | PKR 453.94 | PKR 32.42/capsule | 🔒 Pharma Pro |
| Gotec | Omeprazole | 20 mg | Capsule | 14's | 078859 | PKR 261.47 | PKR 18.68/capsule | 🔒 Pharma Pro |
| Gotec | Omeprazole | 40 mg | Injection | 1's vial | 089441 | PKR 544.73 | PKR 544.73/vial/unit | 🔒 Pharma Pro |
| Grotic | Clarithromycin | 125 mg/5 mL | Suspension | 60ml | 081858 | PKR 404.91 | PKR 6.75/mL | 🔒 Pharma Pro |
| Grotic | Clarithromycin | 125 mg/5 mL | Otic drops | 30ml | 081858 | PKR 199.73 | PKR 6.66/mL | No comparator |
| HYDC | Hydroxychloroquine | 200 mg | Tablet | 50's | 103356 | PKR 777.14 | PKR 15.54/tablet | 🔒 Pharma Pro |
| HYDC | Hydroxychloroquine | 200 mg | Tablet | 30's | 103356 | PKR 466.29 | PKR 15.54/tablet | 🔒 Pharma Pro |
| Lofamin | Levofloxacin | 250 mg | Tablet | 10's | 078860 | PKR 453.94 | PKR 45.39/tablet | 🔒 Pharma Pro |
| Lofamin | Levofloxacin | 500 mg | Tablet | 10's | 078861 | PKR 755.36 | PKR 75.54/tablet | 🔒 Pharma Pro |
| Lorantex | Loratadine | 10 mg | Tablet | 10's | 119327 | PKR 132.95 | PKR 13.30/tablet | 🔒 Pharma Pro |
| Lorantex | Loratadine | 5 mg/5 mL | Syrup | 60ml | 119328 | PKR 90.48 | PKR 1.51/mL | 🔒 Pharma Pro |
| Loretra | Lopinavir + Ritonavir | 200 mg + 50 mg | Tablet | 120's | 103358 | PKR 13,263.27 | PKR 110.53/tablet | 🔒 Pharma Pro |
| Mikaton | Amikacin | 100 mg | Injection | 2ml*1's vial | 081864 | PKR 74.44 | — | No comparator |
| Mikaton | Amikacin | 500 mg | Injection | 2ml*1's vial | 081865 | PKR 226.97 | — | No comparator |
| Mizec | Cefotaxime | 1 g | Injection | 1's vial | 084902 | PKR 281.11 | PKR 281.11/vial/unit | 🔒 Pharma Pro |
| Mizec | Cefotaxime | 500 mg | Injection | 1's vial | 084903 | PKR 156.30 | PKR 156.30/vial/unit | 🔒 Pharma Pro |
| Mizec | Cefotaxime | 250 mg | Injection | 1's vial | 084904 | PKR 103.70 | PKR 103.70/vial/unit | 🔒 Pharma Pro |
| Mondes | Ondansetron | 8 mg/4 mL | IV injection | 5*4ml vial | 081859 | PKR 4,693.73 | — | No comparator |
| Mozex | Moxifloxacin | 400 mg | Tablet | 5's | 078866 | PKR 862.48 | PKR 172.50/tablet | 🔒 Pharma Pro |
| MT-Vir | Oseltamivir | 75 mg | Capsule | 10's | 103359 | PKR 1,295.24 | PKR 129.52/capsule | 🔒 Pharma Pro |
| Noric | Voriconazole | 200 mg | Tablet | 10's | 085779 | PKR 1,997.33 | PKR 199.73/tablet | 🔒 Pharma Pro |
| Noric | Voriconazole | 200 mg | Lyophilized injection | 1's | 108417 | PKR 1,361.82 | PKR 1,361.82/vial/unit | No comparator |
| Pinomer | Meropenem | 500 mg | Sterile powder for injection | 1's | 105973 | PKR 1,847.88 | PKR 1,847.88/vial/unit | No comparator |
| Pinomer | Meropenem | 1 g | Dry powder for injection | 1's | 105974 | PKR 3,453.98 | PKR 3,453.98/vial/unit | No comparator |
| Prufie | Ibuprofen | 100 mg/5 mL | Suspension | 90ml | 081857 | PKR 101.62 | PKR 1.13/mL | 🔒 Pharma Pro |
| Prufie | Ibuprofen | 100 mg/5 mL | Suspension | 120ml | 081857 | PKR 135.50 | PKR 1.13/mL | 🔒 Pharma Pro |
| Prufie | Ibuprofen | 100 mg/5 mL | Suspension | 60ml | 081857 | PKR 67.75 | PKR 1.13/mL | 🔒 Pharma Pro |
| Rokky | Cefuroxime | 750 mg | Injection | 1's vial | 084912 | PKR 181.58 | PKR 181.58/vial/unit | 🔒 Pharma Pro |
All 31 MTI MEDICAL brands in Pakistan
- Amphotericin B Amphotericin B · 50 mg injection
- Antamin Ketamine · 500 mg injection
- Apholac Lactulose · 3.35 g/5 mL solution
- Arpes Aciclovir · 250 mg injection
- Bactidim Ceftazidime · 1 g injection, 250 mg injection
- Celsius Paracetamol · 120 mg suspension, 120 mg/5 mL suspension
- Clomate Clomifene citrate · 50 mg tablet
- Colimate Colistimethate sodium · 1 MIU injection
- Cyto Ciprofloxacin · 250 mg tablet, 250 mg/5 mL suspension, 500 mg tablet
- Cytozon Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Dopacin HCl Dopamine HCl · 200 mg/5 mL injection
- Dragrel Clopidogrel · 75 mg tablet
- Gotec Omeprazole, Omeprazole enteric coated pellets · 20 mg capsule, 40 mg injection, 40 mg capsule
- Grotic Clarithromycin · 125 mg/5 mL suspension, 125 mg/5 mL drops
- HYDC Hydroxychloroquine · 200 mg tablet
- Lofamin Levofloxacin · 250 mg tablet, 500 mg tablet
- Lorantex Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Loretra Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Mikaton Amikacin · 100 mg injection, 500 mg injection
- Mizec Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Mondes Ondansetron · 8 mg/4 mL injection
- Mozex Moxifloxacin · 400 mg tablet
- MT-Vir Oseltamivir · 75 mg capsule
- Noric Voriconazole · 200 mg injection, 200 mg tablet
- Pinomer Meropenem · 1 g injection, 500 mg injection
- Prufie Ibuprofen · 100 mg/5 mL suspension
- Rokky Cefuroxime · 1.5 g injection, 750 mg injection
- Simvaton Simvastatin · 20 mg tablet
- Tazoprid Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
- Vinvin Vancomycin · 1 g injection, 500 mg injection
- Zecmo Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
MTI MEDICAL: common questions
How many products does MTI MEDICAL have in Pakistan?
MTI MEDICAL (PVT.) LTD has 59 registered medicine presentations in Pakistan, sold under 31 brands and covering 32 generic medicines.
What are the main brands of MTI MEDICAL?
By number of registered strengths and packs, its largest brands are Cytozon (Ceftriaxone), Cyto (Ciprofloxacin), Gotec (Omeprazole, Omeprazole enteric coated pellets), Mizec (Cefotaxime) and Prufie (Ibuprofen). This is not a sales ranking.
Which therapy areas does MTI MEDICAL cover?
The most products are in Anti-infectives (41), Gastrointestinal & hepatology (6), Pain & musculoskeletal (5), Cardiovascular (2) and Respiratory & allergy (2).
Where can I see MTI MEDICAL medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.